Session 3 : HER2+ve Breast Cancer

HER2+ve Breast Cancer by Shaheenah Dawood

Chairpersons :

A K Malhotra, S H Advan

Speaker :

Shaheenah Dawood

Association of Polymorphisms in FCGR2A and FCGR3AWith Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer Analysis of the NSABP B31 Trial

Author: Patrick G. Gavin

Reference: JAMA Oncol. 2016 Nov 3

Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab A Secondary Analysis of the HER A Trial

Author: Sherene Loi

Ref erence: JAMA Oncol. 2016 Aug 1;2(8):1040-7

Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial

Author: Edith A. Perez

Reference: J Natl Cancer Inst. 2016 Oct 28;109(2)